| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIABETES.48.1.170 |
| P698 | PubMed publication ID | 9892239 |
| P50 | author | Steven E. Kahn | Q41640212 |
| Carla J Greenbaum | Q88112312 | ||
| Jerry P. Palmer | Q124249485 | ||
| P2093 | author name string | K L Sears | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| autoantibody | Q785022 | ||
| cell function | Q95674809 | ||
| P304 | page(s) | 170-175 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study | |
| P478 | volume | 48 |
| Q53647613 | Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study. |
| Q34166421 | Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure |
| Q73163495 | Beta cell and insulin antibodies in treated and untreated diabetic cats |
| Q89999336 | Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes |
| Q55262290 | Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies. |
| Q45057620 | Conformation-dependent GAD65 autoantibodies in diabetes |
| Q33215130 | Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies |
| Q34274380 | Disease-associated autoantibodies as predictive markers of type 1 diabetes mellitus in siblings of affected children |
| Q77731175 | GAD65 and IA-2 autoantibodies are common in a subset of siblings of Sardinian Type 2 diabetes families |
| Q37333550 | GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes |
| Q46877730 | Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset |
| Q34733637 | Insulin resistance in type 1 diabetes |
| Q57449485 | Islet autoantibodies in the prediction of diabetes in school children |
| Q34630695 | Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects |
| Q37437161 | Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. |
| Q35093549 | Prediabetes in children: natural history, diagnosis, and preventive strategies |
| Q37326608 | Presence of diabetes risk factors in a large U.S. eighth-grade cohort. |
| Q36906258 | Prevalence of the metabolic syndrome among a racially/ethnically diverse group of U.S. eighth-grade adolescents and associations with fasting insulin and homeostasis model assessment of insulin resistance levels |
| Q34351648 | Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes |
| Q33688616 | Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset |
| Q40857843 | Selecting culprits in type 1 diabetes beta-cell killing |
| Q36858479 | The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 α1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults. |
| Q37147347 | The clinical measures associated with C-peptide decline in patients with type 1 diabetes over 15 years |
| Q34056958 | The molecular specificity of insulin autoantibodies |
| Q35934762 | Type 1 diabetes as a model for prediction and diagnosis |
Search more.